Lv5
1528 积分 2023-07-09 加入
Phase 1 Trial with Soquelitinib, a Selective ITK Inhibitor for Treatment of Relapsed/Refractory T Cell Lymphomas
1个月前
已完结
Synthesis and characterization of soquelitinib a selective ITK inhibitor that modulates tumor immunity
1个月前
已完结
ITK and RLK Inhibitor PRN694 Improves Skin Disease in Two Mouse Models of Psoriasis
1个月前
已完结
Protein kinases: drug targets for immunological disorders
1个月前
已完结
Pilot trial of ibrutinib in patients with relapsed or refractory T-cell lymphoma
1个月前
已关闭
How I treat the peripheral T-cell lymphomas
1个月前
已完结
Integrated mate-pair and RNA sequencing identifies novel, targetable gene fusions in peripheral T-cell lymphoma
1个月前
已关闭
The fusion kinase ITK-SYK mimics a T cell receptor signal and drives oncogenesis in conditional mouse models of peripheral T cell lymphoma
1个月前
已关闭
Novel t(5;9)(q33;q22) fuses ITK to SYK in unspecified peripheral T-cell lymphoma
1个月前
已完结
Inhibition of the IL-2-inducible tyrosine kinase (Itk) activity: a new concept for the therapy of inflammatory skin diseases
1个月前
已完结